Results of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) trial, which compared dapagliflozin (10 mg once daily) to placebo, found that dapagliflozin was associated with a 44% reduction in a composite of adverse kidney outcomes and a 29% reduction in death from cardiovascular causes or hospitalization for heart failure
Vitamin B12 is also necessary for maintaining the health of your nervous system
If it lingers, it begins to damage liver cells
10.1016/j.phymed.2018.11.020 Summary Keywords acetaminophen, liver injury, natural products, oxidative stress, Nrf2 Citation Liao J, Lu Q, Li Z, Li J, Zhao Q and Li J (2023) Acetaminophen-induced liver injury: Molecular mechanism and treatments from natural products
These are not randomized controlled trials
Naowaboot 2012